Skip to search formSkip to main contentSkip to account menu

Ethyol

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The objective of this study was to determine the toxicity and efficacy of the current phase II chemoradiation protocol. Stage III… 
2004
2004
Amifostine (Ethyol®) is a cytoprotective drug approved for the reduction of xerostomia in head and neck cancer when administered… 
Review
2003
Review
2003
The chemo- and radioprotectant drug amifostine (Ethyol; MedImmune, Inc, Gaithersburg, MD) is approved for intravenous (IV… 
Highly Cited
2000
Highly Cited
2000
Purpose: Amifostine (WR-2721), a phosphorylated aminothiol pro-drug which is an analogue of cysteamine, is a selective… 
1997
1997
Amifostine was developed as a radio- and chemoprotective agent. It has shown protection against whole-body irradiation, and myelo… 
Review
1994
Review
1994
Radiotherapeutic studies with amifostine (WR-2721; Ethyol, US Bioscience, Inc, West Conshohocken, PA) are reviewed, with evidence… 
1994
1994
The protective action of amifostine (Ethyol, US Bioscience, Inc. West Conshohocken, PA) against the toxic effects of… 
1994
1994
The reported studies tested whether amifostine could be used to protect hemopoietic stem cells, which, after irradiation, could…